Telemedicine (TM) contributes to bridge the gap between healthcare facilities and patients' homes with neuromuscular disease (NMD) because of mobility issues. However, its deployment is limited due to difficulties evaluating subtle neurological signs such as mild weakness or sensory deficits. The COVID-19 pandemic has disrupted healthcare delivery worldwide, necessitating rapid measures implementation by health care providers (HCPs) to protect patients from acquiring SARS-CoV-2 while maintaining the best care and treatment.

Telemedicine in Neuromuscular Diseases During Covid-19 Pandemic: ERN-NMD European Survey / L. El-Hassar, A. Amara, B. Sanson, O. Lacatus, A. Amir Belhouchet, M. Kroneman, K. Claeys, J.P. Plançon, C. Rodolico, G. Primiano, F. Trojsi, M. Filosto, T.E. Mongini, S. Bortolani, M. Monforte, E. Carraro, L. Maggi, F. Ricci, V. Silani, D. Orsucci, A. Créange, Y. Péréon, T. Stojkovic, N.A.M.E. van der Beek, A. Toscano, D. Pareyson, S. Attarian, P.Y.K. Van den Bergh, G. Remiche, J.G.J. Hoeijmakers, U. Badrising, N.C. Voermans, A.M. Kaindl, U. Schara-Schmidt, B. Schoser, E. Gazzerro, J. Haberlová, S. Voháňka, E. Pál, M.J. Molnar, L. Leonardis, I.L. Tournev, A.N. Osorio, M. Olivé, N. Muelas, J. Alonso-Perez, M. de Visser, G. Siciliano, S. Sacconi. - In: JOURNAL OF NEUROMUSCULAR DISEASES. - ISSN 2214-3599. - (2022), pp. 1-12. [Epub ahead of print] [10.3233/JND-221525]

Telemedicine in Neuromuscular Diseases During Covid-19 Pandemic: ERN-NMD European Survey

V. Silani;
2022

Abstract

Telemedicine (TM) contributes to bridge the gap between healthcare facilities and patients' homes with neuromuscular disease (NMD) because of mobility issues. However, its deployment is limited due to difficulties evaluating subtle neurological signs such as mild weakness or sensory deficits. The COVID-19 pandemic has disrupted healthcare delivery worldwide, necessitating rapid measures implementation by health care providers (HCPs) to protect patients from acquiring SARS-CoV-2 while maintaining the best care and treatment.
Covid-19; Europe; Telemedicine; neuromuscular diseases;
Settore MED/26 - Neurologia
11-nov-2022
Article (author)
File in questo prodotto:
File Dimensione Formato  
El-Hassar JND 2022.pdf

accesso aperto

Tipologia: Post-print, accepted manuscript ecc. (versione accettata dall'editore)
Dimensione 1.78 MB
Formato Adobe PDF
1.78 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/947195
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact